Aaron Schacht is the founder of BiomEdit. BiomEdit has raised $58M in total funding. Latest round: Series B. Backed by Anterra Capital.
Aaron Schacht is the Co-founder and CEO of BiomEdit, a biotechnology company founded in 2022 as a spin-out from Elanco Animal Health. He secured a $40 million Series A financing round and later led the company through a $18.4 million Series B fundraising round.
Full founder directory · Investor directory · Company funding database · Fundraising library